OBJECTIVES/HYPOTHESIS: Primary curative treatment of advanced laryngeal cancer may include surgery or chemoradiation, although recommendations vary and both are associated with complications. We evaluated predictors and trends in the use of these modalities and compared rates of complications and overall survival in a population-based cohort of older adults. STUDY DESIGN: Retrospective population-based cohort study. METHODS: Using Surveillance Epidemiology and End Results (SEER) cancer registry data linked with Medicare claims, we identified patients over 65 with advanced laryngeal cancer diagnosed 1999 to 2007 who had total laryngectomy (TL) or chemoradiation (CTRT) within 6 months following diagnosis. We identified complications and estimated the impact of treatment on overall survival, using propensity score methods. RESULTS: The proportion of patients receiving TL declined from 74% in 1999 to 26% in 2007 (P < 0.0001). Almost 20% of the CTRT patients had a tracheostomy following treatment, and 57% had a feeding tube. TL was associated with an 18% lower risk of death, adjusting for patient and disease characteristics. The benefit of TL was greatest in patients with the highest propensity to receive surgery. CONCLUSION: TL remains an important treatment option in well selected older patients. However, treatment selection is complex; and factors such as functional status, patient preference, surgeon expertise, and post-treatment support services should play a role in treatment decisions. LEVEL OF EVIDENCE: 2b. Laryngoscope, 124:2707-2713, 2014.
OBJECTIVES/HYPOTHESIS: Primary curative treatment of advanced laryngeal cancer may include surgery or chemoradiation, although recommendations vary and both are associated with complications. We evaluated predictors and trends in the use of these modalities and compared rates of complications and overall survival in a population-based cohort of older adults. STUDY DESIGN: Retrospective population-based cohort study. METHODS: Using Surveillance Epidemiology and End Results (SEER) cancer registry data linked with Medicare claims, we identified patients over 65 with advanced laryngeal cancer diagnosed 1999 to 2007 who had total laryngectomy (TL) or chemoradiation (CTRT) within 6 months following diagnosis. We identified complications and estimated the impact of treatment on overall survival, using propensity score methods. RESULTS: The proportion of patients receiving TL declined from 74% in 1999 to 26% in 2007 (P < 0.0001). Almost 20% of the CTRT patients had a tracheostomy following treatment, and 57% had a feeding tube. TL was associated with an 18% lower risk of death, adjusting for patient and disease characteristics. The benefit of TL was greatest in patients with the highest propensity to receive surgery. CONCLUSION: TL remains an important treatment option in well selected older patients. However, treatment selection is complex; and factors such as functional status, patient preference, surgeon expertise, and post-treatment support services should play a role in treatment decisions. LEVEL OF EVIDENCE: 2b. Laryngoscope, 124:2707-2713, 2014.
Authors: Stephanie A Michal; David J Adelstein; Lisa A Rybicki; Cristina P Rodriguez; Jerrold P Saxton; Benjamin G Wood; Joseph Scharpf; Denise I Ives Journal: Head Neck Date: 2011-10-22 Impact factor: 3.147
Authors: Ian Ganly; Snehal Patel; Jeanette Matsuo; Bhuvanesh Singh; Dennis Kraus; Jay Boyle; Richard Wong; Nancy Lee; David G Pfister; Ashok Shaha; Jatin Shah Journal: Cancer Date: 2005-05-15 Impact factor: 6.860
Authors: Daniel J Givens; Lucy Hynds Karnell; Anjali K Gupta; Gerald H Clamon; Nitin A Pagedar; Kristi E Chang; Douglas J Van Daele; Gerry F Funk Journal: Arch Otolaryngol Head Neck Surg Date: 2009-12
Authors: P A Groome; B O'Sullivan; W J Mackillop; J Irish; K Schulze; L D Jackson; R J Bissett; P F Dixon; L J Eapen; S P Gulavita; J A Hammond; D I Hodson; R G Mackenzie; K M Schneider; P R Warde Journal: Clin Oncol (R Coll Radiol) Date: 2010-09-09 Impact factor: 4.126
Authors: Jonathan Staton; K Thomas Robbins; Lisa Newman; Sandeep Samant; Merry Sebelik; Francisco Vieira Journal: Otolaryngol Head Neck Surg Date: 2002-07 Impact factor: 3.497
Authors: Andy Trotti; Lisa A Bellm; Joel B Epstein; Diana Frame; Henry J Fuchs; Clement K Gwede; Eugene Komaroff; Luba Nalysnyk; Marya D Zilberberg Journal: Radiother Oncol Date: 2003-03 Impact factor: 6.280
Authors: Gregory T Wolf; Emily Bellile; Avraham Eisbruch; Susan Urba; Carol R Bradford; Lisa Peterson; Mark E Prince; Theodoros N Teknos; Douglas B Chepeha; Norman D Hogikyan; Scott A McLean; Jeffery Moyer; Jeremy M G Taylor; Francis P Worden Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-04-01 Impact factor: 6.223
Authors: Maha Al-Gilani; S Andrew Skillington; Dorina Kallogjeri; Bruce Haughey; Jay F Piccirillo Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-10-01 Impact factor: 6.223
Authors: Derek Ems; Sharanya Murty; Bryan Loy; Judith Gallagher; Laura E Happe; Teresa L Rogstad; Debra Finnel; Jimmy D Fernandez Journal: Am Health Drug Benefits Date: 2018-10